PIMA515632

JAK2 Monoclonal Antibody (1C1), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA515632-Each-of-1 In Stock ₹ 52,732.50

PIMA515632 - Each of 1

₹ 52,732.50

In Stock

Quantity

1

Base Price: ₹ 52,732.50

GST (18%): ₹ 9,491.85

Total Price: ₹ 62,224.35

Antigen

JAK2

Classification

Monoclonal

Concentration

Conc. Not Determined

Formulation

ascites with 0.03% sodium azide

Gene Accession No.

O60674

Gene Symbols

JAK2

Immunogen

Purified recombinant fragment of JAK2(745-955aa) expressed in E. Coli.

Regulatory Status

RUO

Gene ID (Entrez)

3717

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

ELISA, Western Blot

Clone

1C1

Conjugate

Unconjugated

Gene

JAK2

Gene Alias

EC 2.7.10.2; Fd17; JAK 2; JAK2; JAK-2; Janus kinase 2; Janus kinase 2 (a protein tyrosine kinase); JTK 10; JTK10; kinase Jak2; THCYT3; Tyrosine-protein kinase JAK2

Host Species

Mouse

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1

Related Products

Img

Thermo Scientific

PIMA515546

--

Img

Thermo Scientific

PIMA515275

--

Img

Thermo Scientific

PIMA515561

--

Img

Thermo Scientific

PIMA515298

--

Img

Thermo Scientific

PIMA515622

--

Img

Thermo Scientific

PIMA515372

--

Img

Thermo Scientific

PIMA515526

--

Img

Thermo Scientific

PIMA515297

--

Description

  • MA5-15632 targets JAK2 in indirect ELISA, WB applications and shows reactivity with Human samples
  • The MA5-15632 immunogen is purified recombinant fragment of JAK2(745-955aa) expressed in E
  • Coli.<br>
  • MA5-15632 detects JAK2 which has a predicted molecular weight of approximately 130.6kDa
  • Janus kinase 2 (JAK2) is a protein tyrosine kinase involved in a specific subset of cytokine receptor signaling pathways and is mutated in polycythemia vera
  • This kinase contains the catalytic domain (JH1) of JAK2
  • The activation of JAKs can lead to the phosphorylation of STAT (signal transducers and activatiors of transcription) proteins, which dimerize and translocate to the nucleus
  • Once translocated to the nucleus, the STAT proteins can modify transcription of numerous genes, including interferon-stimulated genes
  • JAK2 is required for the IFN gamma-receptor complex initiation and JAK1 functions as an amplifier
  • Some studies have suggested that the role of JAK2 might be performed by Tyk2 and JAK3, if they were positioned correctly within the IFN gamma-receptor complex
  • Mutations affecting JAK2 can cause Budd-Chiari syndrome, Polycythemia vera, Thrombocythemia 3, myelofibrosis, or Acute myelogenous leukemia.